What Happened: After conducting a thorough analysis, Carey sold 3,000 shares of CME Group. This information was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission on Monday.

CME GROUP INC (CME) is a large-cap growth stock in the Investment Services industry. The rating using this strategy is 93% based on the firm’s underlying fundamentals and the stock’s valuation.

CME GROUP INC (CME) is a large-cap growth stock in the Investment Services industry. The rating using this strategy is 100% based on the firm’s underlying fundamentals and the stock’s valuation.

An in-depth analysis of recent analyst actions unveils how financial experts perceive CME Group. The following summary ... Analysts typically rate each stock once per quarter.

If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the ...

Please watch the video at Investors.com - Market Analysis ... to Investor's Business Daily's IBD Stock Checkup, CME stock ranks sixth in its group and has a Composite Rating of 96, an EPS Rating ...

After all, its stock price has already risen sharply this year. In my article, I will delve deeper into the market, competitors, growth opportunities, and the financial health of CME. CME Group ...

Many CME Group Inc. (NASDAQ:CME) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When analyzing insider transactions, it is usually more ...

CME Group (NASDAQ:CME) stock slipped 1.4% in Wednesday premarket trading after the derivatives exchange operator delivered slower growth than expected in the first quarter of the year, even as ...